Biotech and healthcare trusts came at the top of performance tables in NAV terms in February, as the sector continues to "claw back losses" suffered prior to the US election, according to investment trust analysts QuotedData.
In NAV terms, all but one members of the AIC's Biotech Technology & Healthcare sector were in the top ten best performing trusts in February, maintaining the momentum the sector has picked up since the US election result. The £234m International Biotechnology and £435m Biotech Growth trusts were up 8.6% and 8.2% respectively during the month, coming second and third after trust of trusts British & American. Meanwhile, the £1.1bn Worldwide Healthcare and £250m Polar Capital Global Healthcare trusts came in at sixth and seventh place in the table, both up by around 7% in NAV terms. The ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
